Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1981 to 1995 of 2208 results for guidelines

  1. Models of person-centred support:- What models of delivering person-centred support are effective and cost effective for people with a learning disability and behaviour that challenges, and their families and carers?What are the views and experiences of people with a learning disability and behaviour that challenges and their family members and carers, of different models of delivering person-centred support?

    the current recommended approach and is at the centre of this service guideline. However, there is little published research about what...

    Research recommendation
    Published
    15 November 2018

  2. The RhinoChill intranasal cooling system for reducing temperature after cardiac arrest (MIB4)

    NICE has developed a Medtech Innovation Briefing (MIB) on the RhinoChill intranasal cooling system

    Medtech innovation briefing
    Published
    1 February 2014

  3. Duration and intensity of psychological treatment:- What is the effectiveness of treating eating disorders with psychological treatments of reduced duration and reduced intensity, compared with standard treatment?

    controlled trials of the psychological treatments recommended in this guideline should be carried out to compare whether a reduced...

    Research recommendation
    Published
    12 October 2018

  4. Record numbers accessing HIV prevention treatment

    Pre-exposure prophylaxis (PrEP) became routinely available through sexual health clinics in 2020, with NICE recommending the tablets for people at high risk of HIV in 2021.

    News
    Last updated
    17 October 2025

  5. Fenfluramine for treating seizures associated with Lennox–Gastaut syndrome in people 2 years and over (TA1050)

    Evidence-based recommendations on fenfluramine (Fintepla) for treating seizures associated with Lennox–Gastaut syndrome in people 2 years and over.

    Technology appraisal guidance
    Published
    26 March 2025
    View recommendations

    Sections for TA1050

  6. Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19 (TA878)

    Evidence-based recommendations on nirmatrelvir plus ritonavir (Paxlovid), sotrovimab (Xevudy) and tocilizumab (RoActemra) for treating COVID-19.

    Technology appraisal guidance
    Last updated
    1 May 2025
    View recommendations

    Sections for TA878

  7. Technology appraisal committee B members

    Find out more about the NICE technology appraisal advisory committee B members and their registered interests

  8. Exagamglogene autotemcel for treating severe sickle cell disease in people 12 years and over (TA1044)

    Evidence-based recommendations on exagamglogene autotemcel (Casgevy) for treating severe sickle cell disease in people 12 years and over.

    Technology appraisal guidance
    Published
    26 February 2025
    View recommendations

    Sections for TA1044

  9. Ulcerative colitis: management (CG166)

    This guidance has been updated and replaced by NICE guideline NG130.

    Clinical guideline
    Published
    26 June 2013

  10. Multiple sclerosis: Management of multiple sclerosis in primary and secondary care (CG8)

    This guidance has been updated and replaced by NICE guideline CG186.

    Clinical guideline
    Published
    26 November 2003

  11. Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease (CG67)

    This guidance has been updated and replaced by NICE guideline CG181.

    Clinical guideline
    Published
    28 May 2008

  12. Heavy menstrual bleeding: assessment and management (CG44)

    This guidance has been updated and replaced by NICE guideline NG88.

    Clinical guideline
    Last updated
    24 August 2016

  13. Venous thromboembolism: reducing the risk for patients in hospital (CG92)

    This guidance has been updated and replaced by NICE guideline NG89.

    Clinical guideline
    Last updated
    1 June 2015

  14. Improving outcomes in haemato-oncology cancer (CSG3)

    This guidance has been updated and replaced by NICE guideline NG47.

    Cancer service guideline
    Published
    22 October 2003

  15. Smoking: brief interventions and referrals (PH1)

    This guidance has been updated and replaced by NICE guideline NG92.

    Public health guideline
    Published
    29 March 2006